TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35260472

Group type: EXPERIMENTAL
Intervention: Bi-level Positive Airway Pressure (BPAP)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Nasal CPAP
Number of subjects: 186
Study: 32756485

Group type: EXPERIMENTAL
Intervention: ADHD knowledge improvement program (two-day duration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Trial group participation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Higher qualification
Number of subjects: 100
Study: 35132875

Group type: EXPERIMENTAL
Intervention: Genotype-guided P2Y12 inhibitor selection
Number of subjects: 3883

Group type: COMPARATOR
Intervention: Conventional P2Y12 inhibitor selection
Number of subjects: 3883
Study: 33615379

Group type: EXPERIMENTAL
Intervention: Fresh medium on D6 (n=603)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Continuous medium from D3 to D7 (n=620)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Fresh medium on D6 (women ≥40 years old)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Continuous medium (women ≥40 years old)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Overall (all women)
Number of subjects: 298
Study: 33563017

Group type: EXPERIMENTAL
Intervention: Prasugrel 3.75 mg/day
Number of subjects: 3747

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg/day
Number of subjects: 3747
Study: 35695197

Group type: EXPERIMENTAL
Intervention: Gaming therapy
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Gaming therapy with additional telerehabilitation
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Constraint‐Induced Movement therapy
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Traditional rehabilitation
Number of subjects: 167

Group type: COMPARATOR
Intervention: All interventions
Number of subjects: 167
Study: 34083234

Group type: EXPERIMENTAL
Intervention: Sequential androgen receptor signaling inhibitors (abiraterone and enzalutamide)
Number of subjects: 202
Study: 33022096

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 157

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 157
Study: 33470732

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (30 min three to five times/week)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (five times weekly)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham-handgrip training (five times weekly)
Number of subjects: 75
Study: 32864734

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 36339427

Group type: EXPERIMENTAL
Intervention: Osteoporosis (OP)
Number of subjects: 0
Study: 33196410

Group type: EXPERIMENTAL
Intervention: Young SMILES intervention group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as usual control group
Number of subjects: 40
Study: 36353346

Group type: EXPERIMENTAL
Intervention: Hypogastric arterial ligation (HAL) before hysterectomy
Number of subjects: 70
Study: 33392969

Group type: EXPERIMENTAL
Intervention: Two-session brief intervention (BI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Six-session combined intervention (CoI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study: 35510164

Group type: EXPERIMENTAL
Intervention: Educational and telemonitoring program
Number of subjects: 15
Study: 34901997

Group type: EXPERIMENTAL
Intervention: COVID-19 convalescent plasma (CCP), approximately 250 mL
Number of subjects: 941

Group type: COMPARATOR
Intervention: Placebo (normal saline), equivalent volume to CCP
Number of subjects: 941
Study: 34531351

Group type: EXPERIMENTAL
Intervention: DBBM + liquid PRF (test)
Number of subjects: 7

Group type: COMPARATOR
Intervention: DBBM alone (control)
Number of subjects: 7
Study: 32467354

Group type: EXPERIMENTAL
Intervention: Engaging Men through Accountable Practice (EMAP)
Number of subjects: 1387

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1387
Study: 36172675

Group type: EXPERIMENTAL
Intervention: Curcumin (2gm/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 34
Study: 35112380

Group type: EXPERIMENTAL
Intervention: Adapted staff training programme
Number of subjects: 932

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 932
Study: 34436846

Group type: EXPERIMENTAL
Intervention: 6.2% carbohydrate solution
Number of subjects: 11

Group type: COMPARATOR
Intervention: Water placebo
Number of subjects: 11
Study: 36196738

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) training consisting of six sessions
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 63
Study: 33029896

Group type: EXPERIMENTAL
Intervention: Electric-powered ionic toothbrush
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 30
Study: 36149841

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (56 or 84 mg) plus a newly initiated oral antidepressant
Number of subjects: 928
Study: 32772861

Group type: EXPERIMENTAL
Intervention: Access to clinicians' visit notes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Survey data on patient and clinician experiences
Number of subjects: 0
Study: 32086791

Group type: EXPERIMENTAL
Intervention: Naldemedine 0.2 mg once daily
Number of subjects: 344

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 344
Study: 35418506

Group type: EXPERIMENTAL
Intervention: 75% e‐cigarettes, high visibility
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: 25% e‐cigarettes, high visibility
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: 75% e‐cigarettes, low visibility
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: 25% e‐cigarettes, low visibility
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: High visibility e‐cigarette retail displays
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Proportion of e‐cigarette images displayed
Number of subjects: 1034
Study: 33459082

Group type: EXPERIMENTAL
Intervention: Computerized neurocognitive testing (CNT) administered after maximal physical exertion (MPE) at recovery intervals of Immediate, 10-minutes, and 20-minutes
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Computerized neurocognitive testing (CNT) administered after maximal physical exertion (MPE) at a 20-minute recovery interval
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control trial (no MPE)
Number of subjects: 30
Study: 32569395

Group type: EXPERIMENTAL
Intervention: Budesolv 10
Number of subjects: 83

Group type: COMPARATOR
Intervention: Rhinocort® Aqua
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 33776428

Group type: EXPERIMENTAL
Intervention: Aclidinium
Number of subjects: 3589
Study: 35690254

Group type: EXPERIMENTAL
Intervention: Single-Tunnel (ST) MPFL reconstruction
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Double-Tunnel (DT) MPFL reconstruction
Number of subjects: 90
Study: 33894370

Group type: COMPARATOR
Intervention: Topical acyclovir therapy (AVT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: AVT + adjunctive PDT
Number of subjects: 45
Study: 34234028

Group type: EXPERIMENTAL
Intervention: Health language training based on mothers' reproductive life narratives
Number of subjects: 0
Study: 36327379

Group type: EXPERIMENTAL
Intervention: NOURISH‐T+ (Nourishing Our Understanding of Role modeling to Improve Support and Health for Healthy Transitions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief NOURISH‐T (Enhanced Usual Care/EUC)
Number of subjects: 0
Study: 33076707

Group type: EXPERIMENTAL
Intervention: Upper Cervical Translatoric Mobilization (UCTM)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Inhibitory Suboccipital Technique (IST)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 32527692

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 1382

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1382
Study: 35030333

Group type: EXPERIMENTAL
Intervention: Erdafitinib 8 mg/day UpT regimen
Number of subjects: 101
Study: 34759278

Group type: EXPERIMENTAL
Intervention: Urban setting
Number of subjects: 37

Group type: COMPARATOR
Intervention: Rural setting
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Indoor microenvironments
Number of subjects: 37

Group type: COMPARATOR
Intervention: Outdoor environments
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Indoor environments
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Personal air sensor
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Skin sensor
Number of subjects: 37
Study: 35843287

Group type: COMPARATOR
Intervention: CF only for 18 hours before CE and simethicone 200mg in 150 ml water immediately prior to CE
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: CF only + 2L of polyethylene glycol (PEG) 12 hours prior
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: CF only + 1L PEG + sodium ascorbate 3 hours prior
Number of subjects: 229
Study: 33508023

Group type: EXPERIMENTAL
Intervention: E. coli O157:H7 related diarrhea
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Rural residence
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Consumption of undercooked meat
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Consumption of raw vegetables and/or fruit juice
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Presence of bloody diarrhea
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Number of under-five children in a household
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Presence of person with diarrhea in a household
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Owning domestic animal
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Uneducated mother
Number of subjects: 378
Study: 36181292

Group type: EXPERIMENTAL
Intervention: 2940 nm Er:YAG laser followed by triamcinolone acetonide and 308 nm excimer laser (Group A)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 2940 nm Er:YAG laser followed by triamcinolone acetonide and 0.1% tacrolimus (Group B)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 21
Study: 33881408

Group type: EXPERIMENTAL
Intervention: Health care professionals' attitudes toward older adults using technology (ATOAUT-10)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Old age salience manipulation in Study 2
Number of subjects: 190
Study: 34424868

Group type: EXPERIMENTAL
Intervention: Carpal tunnel release at various out-of-pocket price options ($250 to $3,000)
Number of subjects: 1408

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation at various out-of-pocket price options ($250 to $3,000)
Number of subjects: 1408

Group type: EXPERIMENTAL
Intervention: Cost-cutting measures (older-generation implants)
Number of subjects: 1408
Study: 32763624

Group type: EXPERIMENTAL
Intervention: Prosthetic foot stiffness category
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Relative foot stiffness perception
Number of subjects: 17
Study: 35195344

Group type: EXPERIMENTAL
Intervention: Supervised exercise program (exercise routines three times weekly and once weekly on discharge for 6 weeks supervised by a physical therapist)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 40
Study: 33752768

Group type: EXPERIMENTAL
Intervention: Power (measured through scales assessing interpersonal power)
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Experimental manipulation of conflict's seriousness and power (in Studies 2-3)
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Hierarchical regression analyses
Number of subjects: 728
Study: 32348038

Group type: EXPERIMENTAL
Intervention: 3D printing plates
Number of subjects: 18

Group type: COMPARATOR
Intervention: iliosciatic plates fixation system
Number of subjects: 18

Group type: COMPARATOR
Intervention: 2 parallel reconstruction plates fixation system
Number of subjects: 18
Study: 34624497

Group type: EXPERIMENTAL
Intervention: Tailored chemotherapy (T), n = 384
Number of subjects: 773

Group type: COMPARATOR
Intervention: Standard adjuvant chemotherapy (C), n = 389
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Tailored chemotherapy (T)
Number of subjects: 773

Group type: COMPARATOR
Intervention: Standard adjuvant chemotherapy (C)
Number of subjects: 773
Study: 36115360

Group type: EXPERIMENTAL
Intervention: CEA plus BMT
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: CAS plus BMT
Number of subjects: 513

Group type: COMPARATOR
Intervention: BMT alone
Number of subjects: 513
Study: 32966666

Group type: EXPERIMENTAL
Intervention: Er:YAG laser 2940 nm
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diode laser 980 nm
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both lasers
Number of subjects: 20
Study: 36052889

Group type: EXPERIMENTAL
Intervention: Action observation (AO), motor imagery (MI), and gait training
Number of subjects: 39

Group type: COMPARATOR
Intervention: Gait training
Number of subjects: 39
Study: 33528779

Group type: EXPERIMENTAL
Intervention: Decision support intervention (values clarification exercise and CPR video decision aid)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Decision support intervention
Number of subjects: 200
Study: 33934564

Group type: EXPERIMENTAL
Intervention: Echo-guided optimization (EO)
Number of subjects: 27
Study: 32729662

Group type: EXPERIMENTAL
Intervention: EGCG (epigallocatechin gallate)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (NC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: High-fat (HF)
Number of subjects: 90
Study: 33407777

Group type: EXPERIMENTAL
Intervention: Allogeneic MSC (approximately 1 x 10^6 cells/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo solution (same composition as the experimental treatment, without the MSC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Allogeneic MSC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 20
Study: 34232082

Group type: COMPARATOR
Intervention: Yogurt smoothie (YS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Yogurt smoothie with BB‐12 added prefermentation (PRE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Yogurt smoothie with BB‐12 added postfermentation (POST)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Capsule containing BB‐12 (CAP)
Number of subjects: 36
Study: 32449414

Group type: EXPERIMENTAL
Intervention: mHealth arm with digital data collection, vision screening test and retina evaluation using an integrated mobile application
Number of subjects: 2520

Group type: EXPERIMENTAL
Intervention: Conventional arm with manual data collection and screening tests using Snellen chart and Fundus photography
Number of subjects: 2520

Group type: COMPARATOR
Intervention: Control arm with manual data collection without screening tests
Number of subjects: 2520

Group type: EXPERIMENTAL
Intervention: mHealth method
Number of subjects: 2520

Group type: EXPERIMENTAL
Intervention: Conventional method
Number of subjects: 2520
Study: 36205099

Group type: EXPERIMENTAL
Intervention: 50000 IU/day intramuscular vitamin A for a maximum of two weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group continued their common treatment protocols
Number of subjects: 30
Study: 33496439

Group type: EXPERIMENTAL
Intervention: Kinesio taping + combined chain exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Combined chain exercises
Number of subjects: 60
Study: 32404430

Group type: EXPERIMENTAL
Intervention: LMWH pharmaco‐thromboprophylaxis and GCS
Number of subjects: 1905

Group type: COMPARATOR
Intervention: LMWH pharmaco‐thromboprophylaxis alone
Number of subjects: 1905

Group type: COMPARATOR
Intervention: LMWH alone
Number of subjects: 1905
Study: 34633576

Group type: EXPERIMENTAL
Intervention: Lipo‐MIT
Number of subjects: 60

Group type: COMPARATOR
Intervention: MIT
Number of subjects: 60
Study: 33760270

Group type: EXPERIMENTAL
Intervention: Neuro-linguistic programming (NLP) for 30 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guided imagery relaxation technique for 30 min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32241711

Group type: EXPERIMENTAL
Intervention: MyFood decision support system (app for patients and website for nurses)
Number of subjects: 100
Study: 35588353

Group type: EXPERIMENTAL
Intervention: Physician consultation
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control (audiologist follow-up only)
Number of subjects: 133
Study: 33048456

Group type: EXPERIMENTAL
Intervention: Glecaprevir/Pibrentasvir (GLE/PIB) 300/120 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 0
Study: 32957372

Group type: EXPERIMENTAL
Intervention: Farm work experience
Number of subjects: 600

Group type: COMPARATOR
Intervention: No farm work experience
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Farm work experience (men)
Number of subjects: 600

Group type: COMPARATOR
Intervention: No farm work experience (men)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Farm work experience (women)
Number of subjects: 600

Group type: COMPARATOR
Intervention: No farm work experience (women)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Farm work experience (sensitivity analysis)
Number of subjects: 600

Group type: COMPARATOR
Intervention: No farm work experience (sensitivity analysis)
Number of subjects: 600
Study: 35907909

Group type: EXPERIMENTAL
Intervention: Anterior gastropexy
Number of subjects: 240

Group type: COMPARATOR
Intervention: No anterior gastropexy (control)
Number of subjects: 240
Study: 33448580

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (target <120 mmHg)
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard blood pressure control (target <140 mmHg)
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 9361
Study: 32408396

Group type: EXPERIMENTAL
Intervention: Methylation-H
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methylation-M
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methylation-L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prognostic signature based on six HPV-related methylation sites
Number of subjects: 0
Study: 36064509

Group type: EXPERIMENTAL
Intervention: Usual care plus the text message support program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 40
Study: 34672767

Group type: EXPERIMENTAL
Intervention: Dietary nitrate-rich beetroot juice (4.1 mmol NO3-/day; DNS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study: 34990047

Group type: EXPERIMENTAL
Intervention: Everolimus (EVR)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Mycophenolic acid (MPA)
Number of subjects: 186
Study: 33332454

Group type: EXPERIMENTAL
Intervention: EF-initiated PC-IRV (n = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: VCV (n = 14)
Number of subjects: 28
Study: 36456987

Group type: EXPERIMENTAL
Intervention: Silver-coated locking plates
Number of subjects: 226

Group type: COMPARATOR
Intervention: Uncoated locking plates
Number of subjects: 226
Study: 34455822

Group type: EXPERIMENTAL
Intervention: Patent foramen ovale closure
Number of subjects: 560

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 560
Study: 36222880

Group type: EXPERIMENTAL
Intervention: 10mg dose of amiloride
Number of subjects: 10
Study: 35437037

Group type: EXPERIMENTAL
Intervention: Enhanced Homestead Food Production (EHFP) program (2010-2012)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 134
Study: 35074558

Group type: EXPERIMENTAL
Intervention: Complementary programming
Number of subjects: 2604

Group type: EXPERIMENTAL
Intervention: Public works and complementary programming
Number of subjects: 2604

Group type: EXPERIMENTAL
Intervention: Engaging men in nutrition behaviour change communication
Number of subjects: 2604
Study: 34591935

Group type: EXPERIMENTAL
Intervention: Surgical facemask
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cloth facemask
Number of subjects: 24

Group type: COMPARATOR
Intervention: No facemask
Number of subjects: 24
Study: 36401234

Group type: EXPERIMENTAL
Intervention: Daily vitamin D3 (cholecalciferol) 800 IU and daily calcium citrate 600 mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Only daily calcium citrate 600 mg
Number of subjects: 34
Study: 33252102

Group type: EXPERIMENTAL
Intervention: BoNT‐A injection and rNMES combined (group III)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: BoNT‐A injection (group I)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: rNMES (group II)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (group IV)
Number of subjects: 64
Study: 32241084

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with TPF (docetaxel & cisplatin 75 mg/m2 on D1, and fluorouracil 75 mg/m2 on D1-4) followed by CRT (cisplatin 100 mg/m2 on D1 3-weekly, two times plus radiotherapy 68.4 Gy/30 fractions)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CRT) alone (cisplatin 100 mg/m2 on D1 3-weekly, two times plus radiotherapy 68.4 Gy/30 fractions)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with TPF followed by CRT
Number of subjects: 36

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CRT) alone
Number of subjects: 36
Study: 33294725

Group type: EXPERIMENTAL
Intervention: B-EPIC intervention
Number of subjects: 100
Study: 35733373

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (5000 IU daily for 4 months)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (topiramate with placebo capsule)
Number of subjects: 56
Study: 33333466

Group type: EXPERIMENTAL
Intervention: Lateral wedge insole (LWI) for 3 months in early OA group (n = 17)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no intervention, n = 9)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Lateral wedge insole (LWI) for 3 months in late OA group (n = 13)
Number of subjects: 39